Breast Surgeons Live

 Back to Activities List

Session Title:
High-Risk Lesions
Date & Time:
December 19, 2023, 7:00 PM–8:00 PM ET
1 Hour
CME Deadline:
December 19, 2024
Log in to access members-only content.
Target Audience:
Surgeons with a special interest in the treatment of breast disease.
At the end of this activity, participants will be able to:
  • Learn which high risk breast lesions require surgical excision.
  • Recognize how these high risk breast lesions impact a patient’s risk for breast cancer.
  • Identify what follow up is required for high risk lesions that are excised or not excised.
Management of benign breast lesions is a constantly evolving topic. This webinar will review the current literature, standard of care, as well as state of the art practice.
Welcome and Introduction
Katharine Yao, MD, FACS
Atypical Ductal Hyperplasia and Flat Epithelial Atypia
Farin Amersi, MD, FACS
Fibroepithelial and Phyllodes Tumors
Katharine Yao, MD, FACS
Pleomorphic vs Florid vs Classic
Farin Ameri, MD, FACS
Papilloma w/wo Atypia
Katherine Yao, MD, FACS
Nipple Discharge
Melissa Pilewskie, MD, FACS
How to Follow Patient: Imaging, Chemoprevention, Who to Discharge From Practice
Melissa Pilewskie, MD, FACS
Case Presentations
All Faculty
Moderator—Katharine Yao, MD, FACS
NorthShore University Hospital
Evanston, IL
Farin Amersi, MD, FACS
Cedar Sinai Medical Center
Los Angeles, CA
Melissa Pilewskie, MD, FACS
University of Michigan
Ann Arbor, MI
  1. NCCN Guidelines:
  2. ASBrS Consensus Guideline on Concordance Assessment of Image-Guided Breast Biopsies and Management of Borderline or High-Risk Lesions (Download PDF)
Use the link below to view disclosure information for all individuals and groups involved in the planning, implementation, and evaluation of this educational activity.
View Disclosure Information (pdf)